Sign Up to Connect With Companies
Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year
Remains preferred provider among biopharmaceutical companies
Pitney Bowes and Communisis in 10-year Mail Transformation Program
Long-term contract helps Communisis with its mission to become a world-class leader in transactional services
Sony Pictures Television Networks Launches Global Environmental Responsibility Campaign Called Picture This
Campaign to Launch September 28 in 177 Countries
Masimo Donates $5 Million in Medical Equipment to Assist Jordan in Providing Healthcare to Over 1 Million Syrian Refugees
Relief Effort Progress Highlighted at the Clinton Global Initiative Annual Meeting in New York, September 26-29, 2015
Porter Prize Recognizes the Strategic Acumen of Corporates in India
JSW, Apollo, Reliance Foundation, and others received the Porter Prize 2015 award
Aksigen Hospital Care Introduces a Revolutionary Medical Textile - ARMA
Enters hospital textile market
ECC 2015: GIOTRIF® (afatinib) demonstrates superior survival compared to Tarceva® (erlotinib) for patients with previously treated advanced squamous cell carcinoma of the lung, independent of EGFR mutation status
Data from the LUX-Lung 8 trial showed GIOTRIF® (afatinib*) significantly delayed progression of lung cancer (primary endpoint) and improved overall survival (key secondary endpoint) compared to Tarceva® (erlotinib) in patients with advanc
VARGATEF® plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
VARGATEF® (nintedanib*) plus docetaxel significantly decreased tumour burden and slowed tumour growth over time in lung cancer patients with adenocarcinoma after first-line chemotherapy, compared to docetaxel alonePatients with advanced adenocarci
SevOne Announces $50 Million Financing Round Led by Westfield Capital Management and Bain Capital Ventures
World’s largest network and data center operators rely upon SevOne to manage virtualization, cloud, IoT, and mobile Internet initiatives
125,000 Fans already Registered for Hardwell's Guest List Event in Mumbai
Dance Music Unites Like Never Before
Extending overall survival is less important than quality of life and disease stability for the majority of physicians treating patients with advanced lung cancer following first line-chemotherapy
European survey results analysing the prescribing behaviour of 500 physicians treating advanced adenocarcinoma after first-line chemotherapy announced todayResults showed nearly a third of surveyed physicians considered quality of life-related treatm
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
FDA orphan drug designation for avelumab an important regulatory milestoneMerck-Pfizer Alliance continues to dedicate significant resources to accelerate clinical program for high-priority investigational anti-PD-L1
Celgene’s VIDAZA® (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Anticipated approval could provide new option for population with limited treatmentsExpanded indication brings medicine to elderly AML patients who are not eligible for haematopoietic stem cell transplantationand who have >30% myeloblasts in their bo
CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)
First specific reversal agent for a non-vitamin K antagonist oral anticoagulant (NOAC) to gain CHMP positive opinion1Positive opinion is based on clinical trial results which showed that idarucizumab reverses the anticoagulant effect of dabigatran wi
